메뉴 건너뛰기




Volumn 14, Issue 1, 2006, Pages 41-44

Clinical efficacy of intravenous colistin therapy in combination with ceftazidime in severe MDR P. aeruginosa systemic infections in two haematological patients

Author keywords

Colistin; Haematological patients; P. aeruginosa; Systemic infection

Indexed keywords

CEFTAZIDIME; COLISTIN; CYTARABINE; FLUDARABINE; IDARUBICIN; IMIPENEM; PIPERACILLIN; TAZOBACTAM; VANCOMYCIN; VORICONAZOLE;

EID: 33745214024     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (11)
  • 1
    • 17644389620 scopus 로고    scopus 로고
    • Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
    • Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40, 9, 1333-1341, 2005.
    • (2005) Clin. Infect. Dis. , vol.40 , Issue.9 , pp. 1333-1341
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 2
    • 3843060294 scopus 로고    scopus 로고
    • Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections
    • Tascini C., Gemignani G., Ferranti S., et al. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J. Chemother. 16, 3, 282-287, 2004.
    • (2004) J. Chemother. , vol.16 , Issue.3 , pp. 282-287
    • Tascini, C.1    Gemignani, G.2    Ferranti, S.3
  • 3
    • 0014945506 scopus 로고
    • Acute renal failure due to overdosage of colistin
    • Brown J.M., Dorman D.C., Roy L.P. Acute renal failure due to overdosage of colistin. Med. J. Aust. 2, 20, 923-924, 1970.
    • (1970) Med. J. Aust. , vol.2 , Issue.20 , pp. 923-924
    • Brown, J.M.1    Dorman, D.C.2    Roy, L.P.3
  • 4
    • 0014801502 scopus 로고
    • Adverse effects of sodium colistimethate: Manifestations and specific reaction rates during 317 courses of therapy
    • Koch-Weser J., Sidel V.W., Federman E.B. et al. Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 72, 6, 857-868, 1970.
    • (1970) Ann. Intern. Med. , vol.72 , Issue.6 , pp. 857-868
    • Koch-Weser, J.1    Sidel, V.W.2    Federman, E.B.3
  • 5
    • 0030783691 scopus 로고    scopus 로고
    • Intravenous colistin sulphometate in acute respiratory exacerbation in adult patients with cystic fibrosis
    • Conway S.P., Pond M.N., Watson A. et al. Intravenous colistin sulphometate in acute respiratory exacerbation in adult patients with cystic fibrosis. Thorax 52, 11, 987-993, 1997.
    • (1997) Thorax , vol.52 , Issue.11 , pp. 987-993
    • Conway, S.P.1    Pond, M.N.2    Watson, A.3
  • 6
    • 0035022770 scopus 로고    scopus 로고
    • Bronchoconstriction following nebulised colistin in cystic fibrosis
    • Cunningham S., Prasad A., Collyer L. et al. Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch. Dis. Child. 84, 5, 432-433, 2001.
    • (2001) Arch. Dis. Child. , vol.84 , Issue.5 , pp. 432-433
    • Cunningham, S.1    Prasad, A.2    Collyer, L.3
  • 7
    • 25444462811 scopus 로고    scopus 로고
    • Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria
    • Falagas M.E., Blitziotis I.A., Kasiakou S.K. et al. Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria. B.M.C. Infect. Dis. 5, 1, 24-34, 2005.
    • (2005) B.M.C. Infect. Dis. , vol.5 , Issue.1 , pp. 24-34
    • Falagas, M.E.1    Blitziotis, I.A.2    Kasiakou, S.K.3
  • 8
    • 23044515861 scopus 로고    scopus 로고
    • Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
    • Kasiakou S.K., Michaloupoulos A.S., Soteriades E.S. et al. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob. Agents Chemother. 49, 8, 3136-3146, 2005.
    • (2005) Antimicrob. Agents Chemother. , vol.49 , Issue.8 , pp. 3136-3146
    • Kasiakou, S.K.1    Michaloupoulos, A.S.2    Soteriades, E.S.3
  • 9
    • 13844311296 scopus 로고    scopus 로고
    • Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: The renaissance of an old antibiotic
    • Michaloupoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic. Clin. Microbiol. Infect. 11, 2, 115-121, 2004.
    • (2004) Clin. Microbiol. Infect. , vol.11 , Issue.2 , pp. 115-121
    • Michaloupoulos, A.S.1    Tsiodras, S.2    Rellos, K.3    Mentzelopoulos, S.4    Falagas, M.E.5
  • 10
    • 0026538608 scopus 로고
    • Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia - Ciprofloxacin versus co-trimoxazole plus colistin
    • Donnelly J.P., Meschmeyer G., Daenen S. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia - ciprofloxacin versus co-trimoxazole plus colistin. Eur. J. Cancer 28, 4, 873-878, 1992.
    • (1992) Eur. J. Cancer , vol.28 , Issue.4 , pp. 873-878
    • Donnelly, J.P.1    Meschmeyer, G.2    Daenen, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.